Prescription service

Joi + Blokes review

Joi + Blokes gives a useful twelve-week price comparison and broad support features. Its advertised benefit timeline needs a more restrained clinical explanation.

A closer look at the service.

Read the consultation, follow-up and payment terms before taking the next step.

Visit Joi + BlokesOfficial provider website. No affiliate relationship is currently listed.

Who should look closer

Readers who value a broader care platform and understand the twelve-week purchase and renewal terms.

  • Subscription and one-time twelve-week charges are differentiated.
  • Messaging, coaching and delivery are described.
  • Clinical ineligibility refund language is visible.

Reasons to pause

People choosing primarily on predicted body-fat, muscle or symptom changes from a marketing timeline.

  • A twelve-week supply is not three calendar months exactly.
  • The selected pharmacy and complete testing bill need confirmation.
  • A June 2026 FDA warning addressed separate compounded GLP-1 advertising.
In this review

The supply price is unusually easy to compare

Joi + Blokes lists $559 for a twelve-week subscription supply and $699 for a one-time supply. It also displays monthly equivalents of $186.33 and $233. [1] I would compare the actual twelve-week charge first: twelve weeks and three calendar months are different intervals. The explicit one-time alternative is a practical strength for a reader weighing recurring convenience against flexibility. That clarity earns the service a place on the shortlist. It does not make the lower allocated figure a complete ongoing bill before the chosen preparation, testing and renewal agreement have been established.

Support features have value when roles are clear

The offering describes clinician guidance, coaching, messaging and medication delivery. [1] Those features may be useful to someone who wants support beyond placing a pharmacy order. Ask which questions reach the prescribing clinician, which are handled by a coach and how access works between scheduled appointments. The distinction is especially important if a symptom changes or a laboratory result needs interpretation. A broad support menu should become a workable contact arrangement, not simply a list of benefits. I would also clarify whether a consultation or laboratory panel is a separate purchase before deciding how the total compares with a narrower injection-only program.

Read the outcome timeline cautiously

The product page describes changes in sleep, energy, appearance and body composition over successive months. [1] A timeline can make an uncertain response sound predictable even when individual-results language follows it. The adult GHRH studies have particular populations and endpoints; they do not validate every percentage or sequence in a modern service's pitch. [2] [3] Ask which outcome would justify continuing and what happens if that outcome does not occur. The explanation should be tied to an individual clinical purpose rather than the idea that staying enrolled long enough necessarily unlocks the next stage of improvement.

The FDA letter has a specific scope

FDA issued Joi + Blokes a warning letter dated June 8, 2026 concerning advertising and labeling representations for compounded semaglutide and tirzepatide. [4] It should not be retold as a finding that a sermorelin vial was contaminated or that this sermorelin service was proven ineffective. It is still relevant to how a shopper reads the platform's claims. Ask directly who dispenses the selected prescription and what evidence supports the proposed use. The cited letter does not itself establish subsequent resolution. Keep the regulatory issue accurate and bounded while making the current purchase depend on present, prescription-specific information.

Refund language needs its own boundary

The page says a patient receives a refund if the clinician decides the medication is not appropriate. [1] That is distinct from a right to return a dispensed prescription or recover a payment because the hoped-for benefit did not occur. Before choosing subscription, ask when the next charge is taken, how far ahead changes must be requested and what happens once a pharmacy begins preparing the next order. Save the selected terms. I would be comfortable comparing a longer supply only after those rules are understandable, particularly when the attractive displayed monthly equivalent is attached to a larger shipment.

Who should keep Joi + Blokes in consideration

This is a relevant candidate for someone who wants a broader care platform, values messaging and coaching, and has a considered reason to discuss sermorelin. It is a weaker fit for a buyer relying on the benefit timeline or assuming all testing is included in the medication figure. Compare the written twelve-week agreement with an alternative such as AgelessRx, keeping calendar time, clinical access and actual amount paid together. My preference would turn on the care explanation and clear ongoing obligations. The program has tangible commercial features to assess without treating ambitious body-composition language as an expected personal result.

Understanding the cost

Displayed $559 subscription or $699 one-time for twelve weeks. Confirm testing, selected formulation and renewal schedule; monthly equivalents are not calendar-accurate supply descriptions. [1]

Build your cost estimate

Sources

  1. Joi + Blokes: current official sermorelin product and support terms
  2. Vittone et al. (1997): nightly GHRH 1–29 in older men
  3. Vitiello et al. (2006): randomized GHRH 1–29 study
  4. FDA (June 8, 2026): Joi + Blokes warning letter, compounded GLP-1 advertising

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.